<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:01a03900-cde6-70e8-b963-7782ab8e660b,g:f18925ea-b81b-4660-863c-9324a37c2c66-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.avalotherapeutics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="avtx-20260930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.avalotherapeutics.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_01a03900-cf3d-7462-a98f-dfa296f594a8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01a03900-cf3d-7009-8939-7f448c71aa93" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01a03900-cf3d-7462-a98f-dfa296f594a8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01a03900-cf3d-7009-8939-7f448c71aa93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_01a03900-cf3d-7c20-886d-e541af51ce2b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01a03900-cf3d-7462-a98f-dfa296f594a8" xlink:to="loc_us-gaap_ShortTermInvestments_01a03900-cf3d-7c20-886d-e541af51ce2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_01a03900-cf3d-7550-bccb-6408bfd31cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01a03900-cf3d-7462-a98f-dfa296f594a8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_01a03900-cf3d-7550-bccb-6408bfd31cbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_01a03900-cf3d-780a-95f4-854fd63c40d7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01a03900-cf3d-7462-a98f-dfa296f594a8" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_01a03900-cf3d-780a-95f4-854fd63c40d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_01a03900-cf3d-787a-a599-a6dead88600e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_01a03900-cf3d-7b2f-8c54-b57eda6fabcf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01a03900-cf3d-787a-a599-a6dead88600e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_01a03900-cf3d-7b2f-8c54-b57eda6fabcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_01a03900-cf3d-72b8-8a89-184146d1735e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedRoyaltiesCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01a03900-cf3d-787a-a599-a6dead88600e" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrentAndNoncurrent_01a03900-cf3d-72b8-8a89-184146d1735e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_01a03900-cf3d-7ac4-b0f2-7af5ebe10f32" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01a03900-cf3d-787a-a599-a6dead88600e" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_01a03900-cf3d-7ac4-b0f2-7af5ebe10f32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_01a03900-cf3d-77e1-b719-f99441de66d9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01a03900-cf3d-787a-a599-a6dead88600e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_01a03900-cf3d-77e1-b719-f99441de66d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_01a03900-cf3d-7fb1-b247-0b4d05117038" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_01a03900-cf3d-787a-a599-a6dead88600e" xlink:to="loc_us-gaap_LiabilitiesCurrent_01a03900-cf3d-7fb1-b247-0b4d05117038" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_01a03900-cf3d-73e8-940d-0de7c8df47e1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_01a03900-cf3d-73e5-8ead-f8bd87550986" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_01a03900-cf3d-73e8-940d-0de7c8df47e1" xlink:to="loc_us-gaap_StockholdersEquity_01a03900-cf3d-73e5-8ead-f8bd87550986" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_01a03900-cf3d-7afb-a939-89b1246fa142" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_01a03900-cf3d-73e8-940d-0de7c8df47e1" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_01a03900-cf3d-7afb-a939-89b1246fa142" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_01a03900-cf3d-7406-9f5e-649ac2835248" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_01a03900-cf3d-73e8-940d-0de7c8df47e1" xlink:to="loc_us-gaap_Liabilities_01a03900-cf3d-7406-9f5e-649ac2835248" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_01a03900-cf3d-78ac-b99d-fbb15a5b6897" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_01a03900-cf3d-7ec6-bfaa-1a3e59263053" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01a03900-cf3d-78ac-b99d-fbb15a5b6897" xlink:to="loc_us-gaap_AssetsCurrent_01a03900-cf3d-7ec6-bfaa-1a3e59263053" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_01a03900-cf3d-7dfb-b21d-5a21a3fcec0a" xlink:href="avtx-20260930.xsd#avtx_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01a03900-cf3d-78ac-b99d-fbb15a5b6897" xlink:to="loc_avtx_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_01a03900-cf3d-7dfb-b21d-5a21a3fcec0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_01a03900-cf3d-7a68-ba95-94647eca2739" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01a03900-cf3d-78ac-b99d-fbb15a5b6897" xlink:to="loc_us-gaap_LongTermInvestments_01a03900-cf3d-7a68-ba95-94647eca2739" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_01a03900-cf3d-73f5-950f-f1c069b759c4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01a03900-cf3d-78ac-b99d-fbb15a5b6897" xlink:to="loc_us-gaap_Goodwill_01a03900-cf3d-73f5-950f-f1c069b759c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_01a03900-cf3d-79d8-9098-4e633abe92c7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_01a03900-cf3d-78ac-b99d-fbb15a5b6897" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_01a03900-cf3d-79d8-9098-4e633abe92c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_01a03900-cf3d-7ded-a16f-ba6020ba2773" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_01a03900-cf3d-7db8-bae5-f146658c55f0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_01a03900-cf3d-7ded-a16f-ba6020ba2773" xlink:to="loc_us-gaap_AccountsPayableCurrent_01a03900-cf3d-7db8-bae5-f146658c55f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a03900-cf3d-788a-ac80-14d5db064602" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_01a03900-cf3d-7ded-a16f-ba6020ba2773" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a03900-cf3d-788a-ac80-14d5db064602" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_01a03900-cf3d-7772-8182-d154411925cd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_01a03900-cf3d-75fd-b7e6-7eb1a68d1f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_01a03900-cf3d-7772-8182-d154411925cd" xlink:to="loc_us-gaap_CommonStockValue_01a03900-cf3d-75fd-b7e6-7eb1a68d1f5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_01a03900-cf3d-79f5-af90-046abd33f8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_01a03900-cf3d-7772-8182-d154411925cd" xlink:to="loc_us-gaap_PreferredStockValue_01a03900-cf3d-79f5-af90-046abd33f8b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_01a03900-cf3d-74e7-9027-b57876170e11" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_01a03900-cf3d-7772-8182-d154411925cd" xlink:to="loc_us-gaap_AdditionalPaidInCapital_01a03900-cf3d-74e7-9027-b57876170e11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_01a03900-cf3d-7867-bf7c-cc80208d0df8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_01a03900-cf3d-7772-8182-d154411925cd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_01a03900-cf3d-7867-bf7c-cc80208d0df8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01a03900-cf3d-7547-b0e9-1581fa9940e5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_01a03900-cf3d-7772-8182-d154411925cd" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_01a03900-cf3d-7547-b0e9-1581fa9940e5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avalotherapeutics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" xlink:type="simple" xlink:href="avtx-20260930.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"/>
  <link:calculationLink xlink:role="http://www.avalotherapeutics.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_01a03900-cf3d-7c06-a12c-217fc635eaab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_FairValueAdjustmentOfDerivativeLiability_01a03900-cf3d-7fcd-ad63-de633b7d4612" xlink:href="avtx-20260930.xsd#avtx_FairValueAdjustmentOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_01a03900-cf3d-7c06-a12c-217fc635eaab" xlink:to="loc_avtx_FairValueAdjustmentOfDerivativeLiability_01a03900-cf3d-7fcd-ad63-de633b7d4612" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_01a03900-cf3d-7f95-adbc-ae965ea42a83" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_01a03900-cf3d-7c06-a12c-217fc635eaab" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_01a03900-cf3d-7f95-adbc-ae965ea42a83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_01a03900-cf3d-7ffb-925e-3043c1b2adda" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_01a03900-cf3d-7c06-a12c-217fc635eaab" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_01a03900-cf3d-7ffb-925e-3043c1b2adda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_01a03900-cf3d-7caf-a397-ef1cb8043aff" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_01a03900-cf3d-708c-9213-9bd270b4626f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_01a03900-cf3d-7caf-a397-ef1cb8043aff" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_01a03900-cf3d-708c-9213-9bd270b4626f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_01a03900-cf3d-7634-a28a-cd0594288bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_01a03900-cf3d-7caf-a397-ef1cb8043aff" xlink:to="loc_us-gaap_OperatingIncomeLoss_01a03900-cf3d-7634-a28a-cd0594288bd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_01a03900-cf3d-724c-9cd2-07107eea85f3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_01a03900-cf3d-7c2f-975a-bd7203d2e853" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_01a03900-cf3d-724c-9cd2-07107eea85f3" xlink:to="loc_us-gaap_NetIncomeLoss_01a03900-cf3d-7c2f-975a-bd7203d2e853" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_01a03900-cf3d-77a4-8ce2-3954b4b5c9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_01a03900-cf3d-724c-9cd2-07107eea85f3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_01a03900-cf3d-77a4-8ce2-3954b4b5c9d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_01a03900-cf3d-7cd7-b99f-a1968b700835" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_01a03900-cf3d-722c-b167-c33ec73d1451" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_01a03900-cf3d-7cd7-b99f-a1968b700835" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_01a03900-cf3d-722c-b167-c33ec73d1451" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_01a03900-cf3d-7934-a794-f3483c60c553" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_01a03900-cf3d-7cd7-b99f-a1968b700835" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_01a03900-cf3d-7934-a794-f3483c60c553" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_01a03900-cf3d-7e33-a7fe-6d59f546cb32" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_01a03900-cf3d-7b6b-bab2-1a3415161bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_01a03900-cf3d-7e33-a7fe-6d59f546cb32" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_01a03900-cf3d-7b6b-bab2-1a3415161bb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_01a03900-cf3d-762e-8479-c68d0985975c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_01a03900-cf3d-7e33-a7fe-6d59f546cb32" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_01a03900-cf3d-762e-8479-c68d0985975c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_01a03900-cf3d-7bfd-bfc5-bc7238cc1336" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_01a03900-cf3d-7a0e-8d73-2baeaeebd081" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_01a03900-cf3d-7bfd-bfc5-bc7238cc1336" xlink:to="loc_us-gaap_CostsAndExpenses_01a03900-cf3d-7a0e-8d73-2baeaeebd081" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avalotherapeutics.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="avtx-20260930.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.avalotherapeutics.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_01a03900-cf3d-7f12-8ef7-41154941272c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a03900-cf3d-753e-9977-2a00fcec56fc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_01a03900-cf3d-7f12-8ef7-41154941272c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a03900-cf3d-753e-9977-2a00fcec56fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01a03900-cf3d-7f18-b3d5-e4006b62aa1e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_01a03900-cf3d-7f12-8ef7-41154941272c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01a03900-cf3d-7f18-b3d5-e4006b62aa1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-7f1a-a5d4-d267fde89cae" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_01a03900-cf3d-7f12-8ef7-41154941272c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-7f1a-a5d4-d267fde89cae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_01a03900-cf3d-7d83-be09-80b39a1193c7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:to="loc_us-gaap_NetIncomeLoss_01a03900-cf3d-7d83-be09-80b39a1193c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_01a03900-cf3d-7a2c-82fe-f84a99f29ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_01a03900-cf3d-7a2c-82fe-f84a99f29ad5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_01a03900-cf3d-792d-bb4d-b6360208390c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:to="loc_us-gaap_ShareBasedCompensation_01a03900-cf3d-792d-bb4d-b6360208390c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_01a03900-cf3d-7da1-adab-5eb18d1928b0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_01a03900-cf3d-7da1-adab-5eb18d1928b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_01a03900-cf3d-7971-9004-79c554cff404" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_01a03900-cf3d-7971-9004-79c554cff404" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_01a03900-cf3d-785a-b505-adf34a333cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_01a03900-cf3d-785a-b505-adf34a333cf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_FairValueAdjustmentOfDerivativeLiability_01a03900-cf3d-7fff-bc26-7d441256164f" xlink:href="avtx-20260930.xsd#avtx_FairValueAdjustmentOfDerivativeLiability"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:to="loc_avtx_FairValueAdjustmentOfDerivativeLiability_01a03900-cf3d-7fff-bc26-7d441256164f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_01a03900-cf3d-74d7-955c-4113794e78b3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_01a03900-cf3d-74d7-955c-4113794e78b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_01a03900-cf3d-741a-9b21-94e54f975831" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_01a03900-cf3d-741a-9b21-94e54f975831" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_01a03900-cf3d-78e2-9830-023810dfd81a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_01a03900-cf3d-78e2-9830-023810dfd81a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_01a03900-cf3d-7941-a198-e524e228e65b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_01a03900-cf3d-7941-a198-e524e228e65b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_IncreaseDecreaseInLeaseLiability_01a03900-cf3d-7a41-ad5e-17090a669e93" xlink:href="avtx-20260930.xsd#avtx_IncreaseDecreaseInLeaseLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_01a03900-cf3d-79f4-be0e-c7e5a401ae1d" xlink:to="loc_avtx_IncreaseDecreaseInLeaseLiability_01a03900-cf3d-7a41-ad5e-17090a669e93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01a03900-cf3d-717e-896b-0ea5c6054222" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_01a03900-cf3d-77f2-aa55-d669a6fa12b3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01a03900-cf3d-717e-896b-0ea5c6054222" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_01a03900-cf3d-77f2-aa55-d669a6fa12b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_01a03900-cf3d-7926-a1cb-569526ab36e9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_01a03900-cf3d-717e-896b-0ea5c6054222" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_01a03900-cf3d-7926-a1cb-569526ab36e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a03900-cf3d-7f11-8864-3ce3ef67b6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsInAnUnderwrittenPublicOfferingGross_01a03900-cf3d-70fb-a358-52b68e4cdc30" xlink:href="avtx-20260930.xsd#avtx_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsInAnUnderwrittenPublicOfferingGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a03900-cf3d-7f11-8864-3ce3ef67b6cd" xlink:to="loc_avtx_ProceedsFromIssuanceOfCommonStockAndPreFundedWarrantsInAnUnderwrittenPublicOfferingGross_01a03900-cf3d-70fb-a358-52b68e4cdc30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_01a03900-cf3d-7e85-aa55-845fb6d712a5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a03900-cf3d-7f11-8864-3ce3ef67b6cd" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_01a03900-cf3d-7e85-aa55-845fb6d712a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_01a03900-cf3d-7e99-a2f9-c6f4183e7679" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a03900-cf3d-7f11-8864-3ce3ef67b6cd" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_01a03900-cf3d-7e99-a2f9-c6f4183e7679" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_ProceedsFromVentureDebtFinancingAgreement_01a03900-cf3d-7101-bb58-fdd7bb519a4f" xlink:href="avtx-20260930.xsd#avtx_ProceedsFromVentureDebtFinancingAgreement"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a03900-cf3d-7f11-8864-3ce3ef67b6cd" xlink:to="loc_avtx_ProceedsFromVentureDebtFinancingAgreement_01a03900-cf3d-7101-bb58-fdd7bb519a4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_01a03900-cf3d-7135-975b-a7699feeb7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a03900-cf3d-7f11-8864-3ce3ef67b6cd" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_01a03900-cf3d-7135-975b-a7699feeb7bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_01a0a479-3d54-7a4e-8fd0-d0870227d731" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_01a03900-cf3d-7f11-8864-3ce3ef67b6cd" xlink:to="loc_us-gaap_ProceedsFromStockPlans_01a0a479-3d54-7a4e-8fd0-d0870227d731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_01a03900-cf3d-793f-bca1-6e69193e9e19" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01a03900-cf3d-799d-bbea-0d125750a459" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_01a03900-cf3d-793f-bca1-6e69193e9e19" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_01a03900-cf3d-799d-bbea-0d125750a459" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_01a03900-cf3d-7115-b2ec-0e972d3b4e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_01a03900-cf3d-793f-bca1-6e69193e9e19" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_01a03900-cf3d-7115-b2ec-0e972d3b4e1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_01a03900-cf3d-7cd4-b9e8-0231faa55768" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_01a03900-cf3d-793f-bca1-6e69193e9e19" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_01a03900-cf3d-7cd4-b9e8-0231faa55768" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avalotherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesThatAreMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="avtx-20260930.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesThatAreMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.avalotherapeutics.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesThatAreMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_01a03900-cffa-7fb5-aacc-bd0fe17d5869" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_01a03900-cffa-7ce8-95c8-b3c0538e72f9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_01a03900-cffa-7fb5-aacc-bd0fe17d5869" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_01a03900-cffa-7ce8-95c8-b3c0538e72f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_01a03900-cffa-796f-b06d-0e5f89345f64" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_01a03900-cffa-7fb5-aacc-bd0fe17d5869" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_01a03900-cffa-796f-b06d-0e5f89345f64" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avalotherapeutics.com/role/InvestmentsScheduleofCashEquivalentsandShorttermInvestmentsClassifiedasAvailableforsaleDetails" xlink:type="simple" xlink:href="avtx-20260930.xsd#InvestmentsScheduleofCashEquivalentsandShorttermInvestmentsClassifiedasAvailableforsaleDetails"/>
  <link:calculationLink xlink:role="http://www.avalotherapeutics.com/role/InvestmentsScheduleofCashEquivalentsandShorttermInvestmentsClassifiedasAvailableforsaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleExcludingAccruedInterest_01a03900-cffa-7d45-9187-f24005741645" xlink:href="avtx-20260930.xsd#avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterest_01a03900-cffa-7a8a-ae46-62ab89c509ce" xlink:href="avtx-20260930.xsd#avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleExcludingAccruedInterest_01a03900-cffa-7d45-9187-f24005741645" xlink:to="loc_avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterest_01a03900-cffa-7a8a-ae46-62ab89c509ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleUnrealizedGainsExcludingAccruedInterest_01a03900-cffa-70e8-a207-f5dd652f5915" xlink:href="avtx-20260930.xsd#avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleUnrealizedGainsExcludingAccruedInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleExcludingAccruedInterest_01a03900-cffa-7d45-9187-f24005741645" xlink:to="loc_avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleUnrealizedGainsExcludingAccruedInterest_01a03900-cffa-70e8-a207-f5dd652f5915" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleUnrealizedLossesExcludingAccruedInterest_01a03900-cffa-7d17-8a65-fd7db9a2de68" xlink:href="avtx-20260930.xsd#avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleUnrealizedLossesExcludingAccruedInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleExcludingAccruedInterest_01a03900-cffa-7d45-9187-f24005741645" xlink:to="loc_avtx_CashCashEquivalentsAndDebtSecuritiesAvailableForSaleUnrealizedLossesExcludingAccruedInterest_01a03900-cffa-7d17-8a65-fd7db9a2de68" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avalotherapeutics.com/role/LeasesScheduleofAssetsandLiabilitiesLesseeDetails" xlink:type="simple" xlink:href="avtx-20260930.xsd#LeasesScheduleofAssetsandLiabilitiesLesseeDetails"/>
  <link:calculationLink xlink:role="http://www.avalotherapeutics.com/role/LeasesScheduleofAssetsandLiabilitiesLesseeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_01a03900-cffa-7ea8-bdcc-5b8a60428ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_01a03900-cffa-7854-bc8d-b1ed64dc22d2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_01a03900-cffa-7ea8-bdcc-5b8a60428ad0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_01a03900-cffa-7854-bc8d-b1ed64dc22d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_01a03900-cffa-7061-8a14-00a82cb2be50" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_01a03900-cffa-7ea8-bdcc-5b8a60428ad0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_01a03900-cffa-7061-8a14-00a82cb2be50" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avalotherapeutics.com/role/LeasesScheduleofOperatingLeaseLiabilityDetails" xlink:type="simple" xlink:href="avtx-20260930.xsd#LeasesScheduleofOperatingLeaseLiabilityDetails"/>
  <link:calculationLink xlink:role="http://www.avalotherapeutics.com/role/LeasesScheduleofOperatingLeaseLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_01a03900-cffa-7416-a6f7-d5eb3b30e1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_01a03900-cffa-7e66-b5a4-d4ebe2335d11" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_01a03900-cffa-7416-a6f7-d5eb3b30e1bf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_01a03900-cffa-7e66-b5a4-d4ebe2335d11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_01a03900-cffa-7c39-92f4-0fd50d2365ef" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_01a03900-cffa-7416-a6f7-d5eb3b30e1bf" xlink:to="loc_us-gaap_OperatingLeaseLiability_01a03900-cffa-7c39-92f4-0fd50d2365ef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avalotherapeutics.com/role/LeasesScheduleofOperatingLeaseLiabilityDetails_1" xlink:type="simple" xlink:href="avtx-20260930.xsd#LeasesScheduleofOperatingLeaseLiabilityDetails_1"/>
  <link:calculationLink xlink:role="http://www.avalotherapeutics.com/role/LeasesScheduleofOperatingLeaseLiabilityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_01a03900-cffa-70eb-bf6d-292ef75e87e1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_01a03900-cffa-7215-8fcc-d001df7ff975" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_01a03900-cffa-70eb-bf6d-292ef75e87e1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_01a03900-cffa-7215-8fcc-d001df7ff975" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_01a03900-cffa-7062-8a33-380e90853838" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_01a03900-cffa-70eb-bf6d-292ef75e87e1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_01a03900-cffa-7062-8a33-380e90853838" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avalotherapeutics.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avtx-20260930.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.avalotherapeutics.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a03900-cffa-7fe1-8804-3309234d3621" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_AccruedResearchAndDevelopmentExpensesCurrent_01a03900-cffa-7be5-b6a4-cb6448ad0475" xlink:href="avtx-20260930.xsd#avtx_AccruedResearchAndDevelopmentExpensesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a03900-cffa-7fe1-8804-3309234d3621" xlink:to="loc_avtx_AccruedResearchAndDevelopmentExpensesCurrent_01a03900-cffa-7be5-b6a4-cb6448ad0475" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_AccruedLicenseAndMilestonesCurrent_01a03900-cffa-764a-8e3c-5c2c74294656" xlink:href="avtx-20260930.xsd#avtx_AccruedLicenseAndMilestonesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a03900-cffa-7fe1-8804-3309234d3621" xlink:to="loc_avtx_AccruedLicenseAndMilestonesCurrent_01a03900-cffa-764a-8e3c-5c2c74294656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_01a03900-cffa-74f8-b829-251367cce54d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a03900-cffa-7fe1-8804-3309234d3621" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_01a03900-cffa-74f8-b829-251367cce54d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_AccruedGeneralAndAdministrativeExpensesCurrent_01a03900-cffa-7dbb-85fa-cf5c850dc508" xlink:href="avtx-20260930.xsd#avtx_AccruedGeneralAndAdministrativeExpensesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a03900-cffa-7fe1-8804-3309234d3621" xlink:to="loc_avtx_AccruedGeneralAndAdministrativeExpensesCurrent_01a03900-cffa-7dbb-85fa-cf5c850dc508" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_01a03900-cffa-7ad9-922d-19496bf664af" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a03900-cffa-7fe1-8804-3309234d3621" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_01a03900-cffa-7ad9-922d-19496bf664af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_01a03900-cffa-7b88-8196-5742d31f4895" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_01a03900-cffa-7fe1-8804-3309234d3621" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_01a03900-cffa-7b88-8196-5742d31f4895" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avalotherapeutics.com/role/SegmentsScheduleofResearchandDevelopmentExpensesDetails" xlink:type="simple" xlink:href="avtx-20260930.xsd#SegmentsScheduleofResearchandDevelopmentExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.avalotherapeutics.com/role/SegmentsScheduleofResearchandDevelopmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_01a03900-cffb-7c40-9a5e-06cb13db421a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_NonclinicalExpenses_01a03900-cffb-7f9b-8b39-e2b77dc4c9c1" xlink:href="avtx-20260930.xsd#avtx_NonclinicalExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_01a03900-cffb-7c40-9a5e-06cb13db421a" xlink:to="loc_avtx_NonclinicalExpenses_01a03900-cffb-7f9b-8b39-e2b77dc4c9c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_ClinicalExpenses_01a03900-cffb-7e6e-af6f-e8e17be07f6d" xlink:href="avtx-20260930.xsd#avtx_ClinicalExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_01a03900-cffb-7c40-9a5e-06cb13db421a" xlink:to="loc_avtx_ClinicalExpenses_01a03900-cffb-7e6e-af6f-e8e17be07f6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_ChemistryManufacturingAndControlExpenses_01a03900-cffb-701e-a335-d530d617632a" xlink:href="avtx-20260930.xsd#avtx_ChemistryManufacturingAndControlExpenses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_01a03900-cffb-7c40-9a5e-06cb13db421a" xlink:to="loc_avtx_ChemistryManufacturingAndControlExpenses_01a03900-cffb-701e-a335-d530d617632a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avtx_LicenseAndMilestoneExpenses_01a03900-cffb-7c12-a43c-7d75b6992352" xlink:href="avtx-20260930.xsd#avtx_LicenseAndMilestoneExpenses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_01a03900-cffb-7c40-9a5e-06cb13db421a" xlink:to="loc_avtx_LicenseAndMilestoneExpenses_01a03900-cffb-7c12-a43c-7d75b6992352" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_01a03900-cffb-776b-a436-f9965af3f9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_01a03900-cffb-7c40-9a5e-06cb13db421a" xlink:to="loc_us-gaap_LaborAndRelatedExpense_01a03900-cffb-776b-a436-f9965af3f9c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_01a03900-cffb-77b2-965f-95ae0829630e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_01a03900-cffb-7c40-9a5e-06cb13db421a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_01a03900-cffb-77b2-965f-95ae0829630e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpenses_01a03900-cffb-73b2-a936-04ab441aa78f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherExpenses"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_01a03900-cffb-7c40-9a5e-06cb13db421a" xlink:to="loc_us-gaap_OtherExpenses_01a03900-cffb-73b2-a936-04ab441aa78f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
